RBC Capital Maintains Outperform on Korro Bio, Raises Price Target to $90
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Luca Issi has maintained an Outperform rating on Korro Bio (NASDAQ:KRRO) and increased the price target from $70 to $90.
March 27, 2024 | 2:38 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
RBC Capital has reaffirmed its Outperform rating on Korro Bio and raised the price target from $70 to $90.
The upgrade in price target by a reputable analyst firm like RBC Capital typically signals a strong bullish sentiment towards the stock, suggesting a positive outlook on its future performance. This can lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100